RecruitingNCT05598632

Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry

Sponsor

China National Center for Cardiovascular Diseases

Enrollment

22,000 participants

Start Date

Apr 18, 2023

Study Type

OBSERVATIONAL

Conditions

Atrial Fibrillation Stroke

Summary

This study is aimed to validate the existing stroke risk stratification model for patients with atrial fibrillation (AF) (CHA2DS2-VASc Score, CHADS2 Score, ATRIA score, ABC score, etc.) and establish a new stroke risk assessment model using a nationwide AF -specific registry in China.

Eligibility

Min Age: 18 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This registry study follows Chinese patients with atrial fibrillation (an irregular heart rhythm) to understand what factors increase the risk of stroke or blood clots traveling to other parts of the body. It collects real-world health data over time. **You may be eligible if...** - You are 18 or older - You have a documented history of atrial fibrillation (irregular heartbeat) - You are able to give written informed consent **You may NOT be eligible if...** - You have moderate to severe mitral valve stenosis or a mechanical heart valve - You have had or are planning to have an ablation procedure for atrial fibrillation - You have had or are planning to have a left atrial appendage closure procedure - You are unable to cooperate with follow-up visits Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.